bid

Wednesday, October 16, 2024

Google快讯 - lung cancer

Google
lung cancer
实时更新 2024年10月16日
新闻
New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer — — MET is a common ...
Facebook Twitter 标记为不相关
This combination therapy targets MET-driven resistance, a common issue in patients with EGFR-mutated non-small cell lung cancer, and could represent a ...
Facebook Twitter 标记为不相关
The new cancer research hub supports Aaron Goodarzi and his team as they work to deepen our understanding of the causes of lung cancer.
Facebook Twitter 标记为不相关
查看更多结果 | 修改此快讯
您收到此电子邮件是因为您订阅了Google快讯
RSS 以RSS Feed的形式接收此快讯
发送反馈

No comments:

Post a Comment

Google快讯 - disease

disease 实时更新 ⋅ 2024年10月16日 新闻 AstraZeneca advances science of infectious disease protecti...